Cormorant Asset Management LP 13D and 13G filings for Alpine Immune Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-02-14 3:07 pm Sale |
2023-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
Cormorant Asset Management LP | 2,550,000 4.390% |
-300,000![]() (-10.53%) |
Filing |
2023-10-23 4:02 pm Purchase |
2023-10-11 | 13G | Alpine Immune Sciences, Inc. ALPN |
Cormorant Asset Management LP | 2,850,000 5.790% |
2,850,000![]() (New Position) |
Filing |